Literature DB >> 1533876

Age at onset and life table risks in genetic counselling for Huntington's disease.

P S Harper1, R G Newcombe.   

Abstract

Age related genetic risk data for carrying the gene for Huntington's disease in relatives at risk, based on a previously documented life table approach, are presented in a form allowing ready access for use in genetic counselling. Figures are given for first degree relatives and for second degree relatives showing varying age combinations of consultand and intervening parent at risk. Data are also given for the risk of developing Huntington's disease over varying finite periods in relation to age. The availability of this information in tabular form should help those involved in genetic counselling for this disorder in providing accurate risk estimates to relatives; the data are also of importance for combination with genotype information in predictive testing.

Entities:  

Mesh:

Year:  1992        PMID: 1533876      PMCID: PMC1015921          DOI: 10.1136/jmg.29.4.239

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  12 in total

Review 1.  Very early onset Huntington's disease: genetic mechanism and risk to siblings.

Authors:  D J Clarke; S Bundey
Journal:  Clin Genet       Date:  1990-09       Impact factor: 4.438

2.  Problems in genetic prediction for Huntington's disease.

Authors:  M J Morris; A Tyler; L Lazarou; L Meredith; P S Harper
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

3.  Outlook for a clinically normal child in a sibship with congenital myotonic dystrophy.

Authors:  T O'Brien; R G Newcombe; P S Harper
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

4.  Huntington's chorea in South Wales: mutation, fertility, and genetic fitness.

Authors:  D A Walker; P S Harper; R G Newcombe; K Davies
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

5.  Factors influencing age at onset and duration of survival in Huntington's chorea.

Authors:  R G Newcombe; D A Walker; P S Harper
Journal:  Ann Hum Genet       Date:  1981-10       Impact factor: 1.670

6.  Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.

Authors:  J B Penney; A B Young; I Shoulson; S Starosta-Rubenstein; S R Snodgrass; J Sanchez-Ramos; M Ramos-Arroyo; F Gomez; G Penchaszadeh; J Alvir
Journal:  Mov Disord       Date:  1990       Impact factor: 10.338

Review 7.  Huntington disease: genetics and epidemiology.

Authors:  P M Conneally
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

8.  Huntington's Chorea in the Netherlands. The problem of genetic heterogeneity.

Authors:  L N Went; M Vegter-van der Vlis; G W Bruyn; W S Volkers
Journal:  Ann Hum Genet       Date:  1983-07       Impact factor: 1.670

9.  Age of onset in siblings of persons with juvenile Huntington disease.

Authors:  M R Hayden; J A Soles; R H Ward
Journal:  Clin Genet       Date:  1985-08       Impact factor: 4.438

10.  Huntington disease in Georgia: age at onset.

Authors:  P Adams; A Falek; J Arnold
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

View more
  9 in total

Review 1.  Medical ethics for the genome world: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Kelly E Ormond
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

2.  Amyotrophic lateral sclerosis in a patient with a family history of huntington disease: genetic counseling challenges.

Authors:  Andrea L Smith; James W Teener; Brian C Callaghan; Jack Harrington; Wendy R Uhlmann
Journal:  J Genet Couns       Date:  2014-04-26       Impact factor: 2.537

3.  Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.

Authors:  P S Harper; C Lim; D Craufurd
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

4.  Paradox of a better test for Huntington's disease.

Authors:  A Maat-Kievit; M Vegter-van der Vlis; M Zoeteweij; M Losekoot; A van Haeringen; R Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 5.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

6.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

Authors:  A Tyler; D Ball; D Craufurd
Journal:  BMJ       Date:  1992-06-20

7.  Crime in Huntington's disease: a study of registered offences among patients, relatives, and controls.

Authors:  P Jensen; K Fenger; T G Bolwig; S A Sørensen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

8.  Estimating decreased risks for Huntington disease without a test.

Authors:  Reinier Timman; Benno Bonke; Theo Stijnen; Aad Tibben; Anneke Maat-Kievit
Journal:  Eur J Epidemiol       Date:  2008-01-30       Impact factor: 8.082

9.  The epidemiology of Huntington's disease in Northern Ireland.

Authors:  P J Morrison; W P Johnston; N C Nevin
Journal:  J Med Genet       Date:  1995-07       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.